Skip to main content
. Author manuscript; available in PMC: 2019 Nov 12.
Published in final edited form as: Vaccine. 2017 Nov 20;36(47):7192–7197. doi: 10.1016/j.vaccine.2017.10.061

Table 2.

Acute gastroenteritis hospitalizations and percent acute gastroenteritis hospitalizations and reductions by surveillance period, children <60 months, Centre Hospitalier National d’Enfants Albert Royer, Senegal– 2011–2017.

Surveillance perioda No. AGEb/total (% AGE) % reduction no. AGE % reduction % AGE P-valuec
All <60 months
Median 2010–2014 336.5/2606 (12.9%) Reference Reference
March 2015–February 2016 261/2880 (9.1%) 22.4 29.8 <0.01
March 2016–February 2017 190/2420 (7.9%) 43.5 39.2 <0.01
0–11 months
Median 2010–2014 161.5/1306 (12.4%) Reference Reference
March 2015–February 2016 118/1482 (8.0%) 26.9 35.6 <0.01
March 2016–February 2017 81/1278 (6.3%) 49.8 48.7 <0.01
12–23 months
Median 2010–2014 99.5/545.5 (18.2%) Reference Reference
March 2015–February 2016 85/534 (15.9%) 1.2 12.7 0.29
March 2016–February 2017 67/466 (14.4%) 32.7 21.2 0.09
24–59 months
Median 2010–2014 58/755 (7.7%) Reference Reference
March 2015–February 2016 58/864 (6.7%) 0 12.6 0.45
March 2016–February 2017 42/676 (6.2%) 27.6 19.1 0.28
a

Surveillance year defined as March of one year to February of the following year; March 2014–February 2015 considered transitional year and excluded from analyses. RV1 introduced November 2014.

b

Acute gastroenteritis.

c

p-value is for % reduction in %AGE.